Ocumension Therapeutics (HKSE:01477) Short-Term Debt : HK$131.3 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Ocumension Therapeutics Short-Term Debt?

Ocumension Therapeutics's Short-Term Debt for the quarter that ended in Dec. 2023 was HK$131.3 Mil.

Ocumension Therapeutics's quarterly Short-Term Debt stayed the same from Dec. 2022 (HK$0.0 Mil) to Jun. 2023 (HK$0.0 Mil) but then increased from Jun. 2023 (HK$0.0 Mil) to Dec. 2023 (HK$131.3 Mil).

Ocumension Therapeutics's annual Short-Term Debt stayed the same from Dec. 2021 (HK$0.0 Mil) to Dec. 2022 (HK$0.0 Mil) but then increased from Dec. 2022 (HK$0.0 Mil) to Dec. 2023 (HK$131.3 Mil).

Ocumension Therapeutics Short-Term Debt Historical Data

The historical data trend for Ocumension Therapeutics's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumension Therapeutics Short-Term Debt Chart

Ocumension Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

131.25

Ocumension Therapeutics Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Debt	Get a 7-Day Free Trial						-	-	-	-	131.25

Ocumension Therapeutics Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Ocumension Therapeutics Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Ocumension Therapeutics's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocumension Therapeutics (HKSE:01477) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocumension Therapeutics (HKSE:01477) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

5DG:Germany

Address

No. 1858 Yinzhongnan Road, Guoxiang Subdistrict, Wuzhong District, Suzhou, Jiangsu, CHN

Website

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602.

Ocumension Therapeutics (HKSE:01477) Headlines

No Headlines